Modes of action and inhibitory activities of new siderophore-β-lactam conjugates that use specific iron uptake pathways for entry into bacteria

Antimicrobial Agents and Chemotherapy

Volumn 36, Issue 10, 1992, Pages 2166-2175

  Brochu, A ^a   Brochu, N ^a   Nicas, T I ^a   Parr Jr , T R ^a   Minnick Jr , A A ^a   Dolence, E K ^a   McKee, J A ^a   Miller, M J ^a   Lavoie, M C ^a   Malouin, F ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM DERIVATIVE; CEFALORIDINE; CEPHALOSPORIN DERIVATIVE; COLICIN; EKD 3 88; GRISEIN; IODINE 125; JAM 2 263; NITROCEFIN; OUTER MEMBRANE PROTEIN; PENICILLIN BINDING PROTEIN; SIDEROPHORE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIOPHAGE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; CROSS RESISTANCE; DRUG CONJUGATION; DRUG PROTEIN BINDING; DRUG TARGETING; DRUG TRANSPORT; ESCHERICHIA COLI; FEMALE; IRON TRANSPORT; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0026728122     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.36.10.2166     Document Type: Article

References (0)